. "Appendix D: Responses to Committee's Questions." A Review of the Dose Reconstruction Program of the Defense Threat Reduction Agency. Washington, DC: The National Academies Press, 2003.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Reply: The CIRRPC screening doses when applicable are used in formulating a medical opinion but other factors are considered as well.
I hope these comments will be of assistance. Please feel free to contact me at 202-273-8452 or by e-mail at neil.otchin@hq.med.va.gov if there are additional questions.
